Patents by Inventor Jonathan P. HULSE

Jonathan P. HULSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS TARGETING APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN WITH CASPASE ACTIVATION AND RECRUITMENT DOMAIN (ASC) AND METHODS OF USE
    Publication number: 20250042962
    Abstract: An immunogen includes an immunogenic carrier and an antigenic apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) peptide linked to the immunogenic carrier. In one or more embodiments, the immunogenic carrier is a Q? virus-like particle (VLP). The immunogen may be formulated into a composition useful for treating inflammatory medical conditions.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 6, 2025
    Inventors: Bryce CHACKERIAN, Kiran BHASKAR, Jonathan P. HULSE
  • Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use
    Patent number: 12162916
    Abstract: An immunogen includes an immunogenic carrier and an antigenic apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) peptide linked to the immunogenic carrier. In one or more embodiments, the immunogenic carrier is a Q? virus-like particle (VLP). The immunogen may be formulated into a composition useful for treating inflammatory medical conditions.
    Type: Grant
    Filed: April 16, 2024
    Date of Patent: December 10, 2024
    Assignees: UNM Rainforest Innovations
    Inventors: Bryce Chackerian, Kiran Bhaskar, Jonathan P. Hulse
  • COMPOSITIONS TARGETING APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN WITH CASPASE ACTIVATION AND RECRUITMENT DOMAIN (ASC) AND METHODS OF USE
    Publication number: 20240279295
    Abstract: An immunogen includes an immunogenic carrier and an antigenic apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) peptide linked to the immunogenic carrier. In one or more embodiments, the immunogenic carrier is a Q? virus-like particle (VLP). The immunogen may be formulated into a composition useful for treating inflammatory medical conditions.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 22, 2024
    Inventors: Bryce CHACKERIAN, Kiran BHASKAR, Jonathan P. HULSE